Biodonostia Health Research Institute

Ikerketa erakundeak

The Institute preferentially boosts translational research focusing on the patient; it covers all research carried out in Gipuzkoa within the framework of the Basque Health Service (Osakidetza – SVS) and aims to improve people’s health through its multi-institutional and inter-disciplinary collaborative structure. This website aims to be a showcase of our activity.

There have been many milestones along the way since it was created back in 2008, thanks to the commitment shown by the researchers, public bodies and other funding bodies. Out of all these milestones, the inauguration of the renovated building in 2010 and its accreditation in 2011 as a Health Research Institute by the prestigious Carlos III Institute of Health (Instituto de Salud Carlos III) should be highlighted. What is more, the Biodonostia HRI was re-accredited in 2016 and in 2021, which meant that it remained at the elite group of accredited Health Institutes at a national level.

Our research is arranged in 7 Vertical Research Areas and 3 Cross-cutting Research Areas that bring together around 350 researchers in 29 groups. With the purpose of boosting scientific advances, the Biodonostia HRI has managed to establish a unique composition that makes it stand out from all the other Institutes, through the integration of the most important technological agents in Gipuzkoa.

The core of the Institute is the Donostialdea IHO (Integrated Health Organisation), and its field of reference is constituted by the IHOs in the territory of Gipuzkoa: Bidasoa, Debabarrena, Debagoiena, Goierri-Urola Garaia and Tolosaldea. Like the majority of Health Research Institutes, it is also part of the University, in our case the University of the Basque Country (UPV – EHU). Also incorporated at this level are the Gipuzkoa Provincial Council, the Euskampus Foundati on and the Ikerbasque Foundation, thanks to which it has been possible to increase the critical mass of researchers by incorporating personnel of widespread international renown.

The Institute’s singular nature lies in its other members. The Gipuzkoa Science and Technology Park is home to a vast number of technology-based centres, among which are the centres forming part of the Institute: Vicomtech, Cidetec, Osatek, Matía Gerontological Institute and Onkologikoa, as well as other partner centres not falling within its Governing Bodies: BCBL, CIC nanoGUNE, CIC biomaGUNE, CITA Alzheimer, the Dr Carlos Elosegui Foundation at the Policlínica Gipuzkoa and Tecnalia. The research subjects tackled are: micro and nano biotechnologies, biomaterials, molecular imaging, and audiovisual technologies, e-health, gerontology, cognition, brain and language, among others.

The Institute aspires to be an international centre of reference in the field of health research and preferentially promotes innovation in medical and health technologies with the aim of advancing in sustainability of the system. It therefore participates in the ITEMAS ISCIII Platform (Platform for Innovation in Medical and Healthcare Technologies), known from 2021 as Revitalisation and innovation of the industrial capacities of the NHS and their effective transfer to the production sector. Today the Biodonostia HRI sits on the ITEMAS Board of Directors, whose role is to provide support and backing to the Coordinator of the Platform in its key areas. It also participates in the SCReN (Clinical Research and Clinical Trial Units Platform) as one of the hubs making up the endeavour at state level. It has now renewed its membership of the new ISCIII Platform lending support to R&D&I in Biomedicine and Health Sciences – Support for clinical research.

The Institute is also part of REGIC, the first Association of Clinical Research Managing Bodies, created in Spain at the instance of professionals to share experiences and create a space for interaction and training in the management of health care R&D.
Lastly, worthy of note is the fact that since 2016 the Institute has been participating in the EATRIS (European Infrastructure for Translational Medicine) Platforms for Advanced Therapy Medicinal Products, Biomarkers and Vaccinations. Recently, EATRIS Spain, in collaboration with the Carlos III Health Institute, within its functions of reinforcing its strategic agenda and promoting the participation of accredited HRIs in international activities, has created a Scientific Committee to provide support in the making of strategic decisions at EATRIS Spain. Dr. Estefanía Carrasco from the Oncology Area of the Biodonostia HRI has been selected to sit on that Committee.

Kokapena

Biodonostia Health Research Institute

Biodonostia HRI Pº Dr. Beguiristain s/n 20014 Donostia – San Sebastián Gipuzkoa

Nola iritsi

Kontaktua
T: +34 943 006012